BackNDT Pharmaceuticals Overview
NDT Pharmaceuticals Inc.

NDT Pharmaceuticals PEG Ratio

NDT Pharmaceuticals (NDTP) has a PEG ratio of -0.09, above the Healthcare sector average of -6.46.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-0.09

PEG Ratio

-0.09

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

NDT Pharmaceuticals (NDTP) FAQ

The latest PEG ratio for NDTP is -0.09. That is above the Healthcare sector average of -6.46. Investors often review this figure alongside NDT Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, NDTP currently prints -0.09 for PEG ratio, while the sector average sits near -6.46. That is roughly 98.6% above the sector mean. Large gaps often invite a closer look at NDT Pharmaceuticals's growth, margins, and balance sheet.

A PEG ratio of -0.09 for NDT Pharmaceuticals is not 'good' or 'bad' on its own. Compare it with the peer average (-6.46) and with NDTP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting NDTP's PEG ratio (-0.09), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack NDT Pharmaceuticals's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.